Pharmacotherapy based on medical genetics for smoking cessation

Carissa I. Pardamean, James W. Baurley, Bens Pardamean

Abstract


Indonesia is the fourth highest consumer of cigarettes in the world with an estimated high cost in healthcare expenditure on tobacco-related diseases. Nonetheless, regulations on tobacco products are lax and healthcare provider involvement in aiding smoking cessation is minimal. Generally, a variety of smoking cessation aids exists and medical genetics have come into play to enhance their efficacy. A questionnaire survey was piloted to query participants on their smoking habits, past cessation attempts, opinions on factors related to smoking cessation, and reactions to information that medical genetics could provide within the context of smoking cessation. The findings showed that most participants have attempted cessation without aid. Pharmacotherapy was not used by any respondents while behavioral interventions were scarcely used. Nevertheless, 83% of participants indicated that medical genetics information would be useful in future cessation attempts and that they would consult physicians for advice.

Full Text: PDF

Published: 2021-03-30

How to Cite this Article:

Carissa I. Pardamean, James W. Baurley, Bens Pardamean, Pharmacotherapy based on medical genetics for smoking cessation, Commun. Math. Biol. Neurosci., 2021 (2021), Article ID 27

Copyright © 2021 Carissa I. Pardamean, James W. Baurley, Bens Pardamean. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Commun. Math. Biol. Neurosci.

ISSN 2052-2541

Editorial Office: office@scik.org

 

Copyright ©2021 CMBN